Incannex Healthcare Inc.
Income Statement
| Line Item | Dec 2024 | Sep 2024 |
|---|---|---|
| Revenue | $12.0K | $74.0K |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $1.4M | $2.9M |
| SG&A Expense | $3.6M | $3.4M |
| Operating Income | $-5.0M | $-6.3M |
| Operating Margin | -41,700.0% | -8,451.4% |
| Interest Expense | — | — |
| Pretax Income | $-5.9M | $-5.4M |
| Income Tax Expense | — | — |
| Net Income | $-5.9M | $-5.4M |
| Net Margin | -49,116.7% | -7,324.3% |
| EPS (Basic) | $-0.03 | $-0.03 |
| EPS (Diluted) | $-0.03 | $-0.03 |
| Shares Outstanding (Basic) | 176.2M | 176.4M |
| Shares Outstanding (Diluted) | 176.2M | 176.4M |
| Dividends Per Share | — | — |